Product Information
CARBIDOPA-LEVODOPA 25-100 TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0757 per EA under NDC 62756051813. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Oct 28, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 100 mg/1; mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756051813
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA078536FDA Approved
10/28/2008
TE Code
AB
On Market Since
10/28/2008
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0757 per EA |
|---|---|
| All-time high | $0.1394 (Jun 15, 2022) |
| All-time low | $0.0617 (Nov 20, 2024) |
| 52-week high | $0.0876 |
| 52-week low | $0.0757 |
| Median price | $0.0974 |
| Average price | $0.1011 |
| Largest weekly change | -30.7% (Nov 20, 2024) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-13.6%
3Y
-20.6%
5Y
-22.7%
All
-39.6%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-100 TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.0757 per EA (NDC 62756051813), effective Feb 18, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has declined 39.6%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-100 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has ranged from a low of $0.0617 (Nov 20, 2024) to a high of $0.1394 (Jun 15, 2022), with a median of $0.0974 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-100 TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBIDOPA-LEVODOPA 25-100 TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-100 TAB?
CARBIDOPA-LEVODOPA 25-100 TAB (NDC 62756051813) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.